sulfobromophthalein has been researched along with Bright Disease in 2 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosokawa, S | 1 |
| Tagaya, O | 1 |
| Mikami, T | 1 |
| Nozaki, Y | 1 |
| Kawaguchi, A | 1 |
| Yamatsu, K | 1 |
| Shamoto, M | 1 |
| Milev, B | 1 |
2 other studies available for sulfobromophthalein and Bright Disease
| Article | Year |
|---|---|
A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions.
Topics: Animals; Bilirubin; Chronic Disease; Disease Models, Animal; Female; Glomerulonephritis; Hyperbiliru | 1992 |
[Disorders of liver function in endemic nephropathy].
Topics: Bilirubin; Disease Reservoirs; Europe, Eastern; Galactose; Glomerulonephritis; Humans; Liver Disease | 1972 |